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ABSTRACT 
Human T-lymphotrophic virus type 1 (HTLV-1) is a causative agent of tropic spastic paraparesis and adult T-
cell leukaemia, Information regarding the involvement of HTLV-1 in presentation of some subclinical 
immune suppression that may results in increased rate of HIV and TB infections has long been documented. 
Sixty (60) Confirmed Pulmonary TB subjects consisting of 41 males and 19 females were recruited in this 
study, Tuberculosis was confirmed by collecting their sputum samples and analysed using GeneXpert. The 
prevalence of HTLV-1 IgG antibodies among TB subjects was 6.6%, while that of IgM was 1.6%. Accordingly, 
sexually active couple group has the highest prevalence of 2.3% when compared to single and widow 
categories, age group 15-24 has the highest percentage of 3.3% for HTLV-1 IgG antibodies. 
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RÉSUMÉ                                                                                                                                                                                                                        
Les T-lymphotrope humain de type 1 (HTLV-1) est un agent causal de la paraparésie spastique tropicale et des profils à 
cellules T, de l'information au sujet de l'implication de l'HTLV-1 dans la présentation de certains suppression immunitaire 
subclinique qui peuvent se traduit par une augmentation des taux de VIH et tuberculose. Soixante (60) a confirmé la 
tuberculose pulmonaire (composé de 41 sujets de sexe masculin et 19 de sexe féminin ont été recrutés dans cette étude, la 
tuberculose a été confirmé par la collecte de leurs échantillons d'expectoration et analysées à l'aide d'GeneXpert. La 
prévalence des anticorps IgG HTLV-1 chez les sujets CT était de 6,6 %, tandis que celle d'IgM a été de 1,6  %. En 
conséquence, groupe couple sexuellement actifs a les taux de prévalence de 2,3  % par rapport à une seule et veuve, 
catégories d'âge 15-24 ans a le plus fort pourcentage de 3,3 % pour l'HTLV-1 anticorps IgG. 
Mots clés: HTLV-1, la tuberculose, IgG, IgM
 
INTRODUCTION 
The human T-lymphotropic virus, or human T-cell 
leukaemia-lymphoma virus (HTLV) belongs to the 
family of viruses that are known to cause a type of 
cancer called adult T-cell 
leukaemia/lymphoma and a diseases called HTLV- 
 
I associated myelopathy/tropical spastic 
paraparesis (HAM/TSP). The HTLV-1 genome is 
diploid, composed of two copies of a single-
stranded RNA virus whose genome is copied into a 
double-stranded DNA form that integrates into the 
host cell genome, at which point the virus is 
referred to as provirus (1). 
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Human T-cell lymphotropic virus type 1 (HTLV-1) 
is a human retrovirus that causes persistent 
infection in the host. While most infected persons 
remain asymptomatic carriers (ACs), 3–5% develop 
a T-cell malignancy termed adult T-cell Luekemia 
(ATL), and another 0.25–3% develop a chronic 
progressive inflammatory neurologic disease 
known as HTLV-1-associated myelopathy/tropical 
spastic paraparesis (HAM/TSP) (2). An increased 
prevalence of the virus infection among individuals 
with active TB and higher mortality in co-infected 
individuals are described by several authors (3). 
However, contradictory results are reported in 
other studies (4,5). Furthermore, high frequencies of 
HTLV-1 infection among TB patients have been 
reported in Japan, Nigeria and Brazil (6,7,8). On the 
other hand, in studies conducted in Senegal and 
Papua New Guinea, few TB patients were HTLV-1 
infected (9,10). Fewer studies started with HTLV-1-
infected individuals and looked at the occurrence of 
TB. In one Japanese report, TB history was more 
frequent among HTLV-1-infected than among 
seronegative men (11) In another Japanese study, 
chest X-ray findings compatible with old 
pulmonary TB were more frequent among HTLV-1 
carriers than among non-carriers (12). The present 
research aimed at reporting prevalence of HTLV-1 
antibodies among patients infected with pulmonary 
Tuberculosis (PTB) 
MATERIALS AND METHODS 
Study Design 
The present study is a cross- sectional study. 
Study Population 
Sixty (60) individuals infected PTB with no history 
of other chronic diseases were recruited in this 
study. 
Specimen Collection 
About 5mls of whole blood was collected 
aseptically from each subject using standard 
venepuncture. Samples were dispensed into 
appropriately labelled screw – capped containers 
and was left at room temperature for about an hour, 
after which it was spun at 3,000 rpm for 10minites 
to separate serum from blood clot. Serum were 
dispensed into corresponding labelled plain 
containers and was stored at – 200c until needed for 
assay  
 
Determination of Tuberculosis 
Tubercule bacilli was confirmed using GeneXpert as 
follows; 2 volumes of sample reagent was mixed 
with one part of sample (Ratio 2:1),  
It was mixed vigorously 20 times, incubation at 
room temperature for 10 minutes and mixed again 
until sample liquefies. 2mls of sample was 
transferred into the open port of Xpert MTB/RIF 
Cartridge and lid closed, after 30 minutes, cartridge 
Barcode was scanned using barcode reader of the 
machine. Instrument module door was opened with 
the blinking green light and load cartridge. And the 
result was recorded. 
ELISA technique for HTLV-1 Determination 
Fifty (50µl) of negative and positive controls were 
added to the negative and positive control wells 
respectively. In sample wells, 40µl Sample dilution 
buffer and 10µl sample were added. Samples were 
loaded onto the bottom without touching the well 
wall and mix well with gentle shaking. After 30 
minutes of incubation at room temperature and 
sealed with closure plate membrane, diluted with 
buffer 30 times for 96T and washed 5 times. 50µl 
HRP-Conjugate reagent was added to each well 
except the blank control well, it was incubated for 
30 minutes and washed. 50µl Chromogen Solution 
A and B were added to each well, mixed with 
gentle shaking and incubated at 37 ℃ for 15 
minutes, light was avoided during colouring. 
Lastly, 50µl of stop solution was added to each well 
to terminate the reaction and colour in the well 
changed from blue to yellow. Absorbance was Read 
at 450nm using a Microtiter Plate Reader and OD 
value of the blank control well is set as zero. 
Ethical Clearance 
An ethical approval was obtained from Jigawa State 
Ministry of health ethical committee before the 
commencement of the study, and the 
consent/accent of the subjects was sought for 
during this study. The subject was giving an 
opportunity to accept or reject enrolment into the 
study. 
Statistical Analysis 
The results were entered in Microsoft Excel and 
later transferred in statistical software SPSS Version 
20 and OpenEpi version 2.3 for analysis. 
 
RESULTS                                                                                  
Table 1 shows the prevalence of HTLV-1 IgG and 
IgM antibodies among the Pulmonary Tuberculosis 
patients. Of the sixty screened patients 6.6% that is 
4 tested positive to HTLV-1 IgG antibodies while 
1.6% that is 1 patient tested positive to IgM 
antibodies. The statistical analysis shows that there 
is no significant difference between IgG and IgM 
antibodies among Tuberculosis patients enrolled in 
this study with p-value >0.005.  
Table 2 shows relationship between HTLV-1 IgG 
and IgM antibodies and marital status of the 
Tuberculosis patients. Of the sixty study 
participants 3.2% and 1.6% of the married couples 
tested positive to HTLV-1 IgG and IgM antibodies 
respectively, single couples have 1.6% for IgG and 
0%for IgM antibodies. However, all the participants 
in Divorce category have 1.6% for IgG antibodies 
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and 0% for IgM.  Widow Categories tested negative 
to both IgG and IgM antibodies. 
Table 3 shows age distribution with respect to 
HTLV-1 IgG and IgM antibodies among Pulmonary 
tuberculosis patients. Age group 5-14 and 55-64 all 
tested negative to both IgG and IgM antibodies. 
Age group 15-234 has highest percentage 
prevalence of IgG antibodies with 3.3%, age group 
25-34 and 45-54 have both 1.6%, while 55-64 have 
0% prevalence. Age group 45-54 is the only group 
that have participant who tested positive to HTLV-1 
IgM antibodies 
 
TABLE 1: PREVALENCE OF HTLV -1 IGG AND IGM ANTIBODIES AMONG STUDY POPULATION 
Sex No. Screened IgG (%) IgM (%) 
Male  41 04(6.6) 00 
Female  19 00 01(1.6) 
Total 60 04(6.6) 01(1.6) 
χ2 = 0.7013        P – valve = 0.4017 
 
TABLE 2: MARITAL STATUS AND HTLV -1 IGG AND IGM ANTIBODIES AMONG STUDY POPULATION 
Marital Status  No Screened IgG (%) IgM (%) 
Married  32 02(3.2) 01(1.6) 
Single  21 01(1.6) 0(0.0) 
Divorce  05 01(1.6) 00(0) 
Widow  02 00(0) 00(0) 
Total 60 04(6.6%) 01(1.6%) 
           χ2 = 1.068                              P - valve = 0.381 
TABLE 3: AGE DISTRIBUTION AND HTLV -1 IGG AND IGM ANTIBODIES AMONG PULMONARY TUBERCULOSIS 
PATIENTS 
Age Range  No Screened IgG (%) IgM (%) 
5 – 14  02 00(0) 00(0) 
15 – 24  08 02(3.3) 00(0) 
25 – 34  21 01(1.6) 00(0) 
35 – 44  18 01(1.6) 00(0) 
45 – 54  06 00(0) 00(1.6) 
55 – 64  05 00(0) 00(0) 
Total 60 04(6.6%) 01(1.6%) 
 
DISCUSSION                                                          
According to the results obtained from the present 
study, a percentage prevalence of 6.6% for IgG and 
1.6% IgM antibodies among TB patients were 
recorded, this is in accordance with work of Olaleye 
et al. 1994 (13) who reported a prevalence of 3.6%. 
Degree of subclinical immunosuppression caused 
by HTLV-1 infection has been documented by Goon 
et al., 2004 (14) resulting to other maladies such as 
crusted scabies, strongyloidiasis and Tuberculosis 
(15,8). In this study the percentage prevalence of 
participants who are Tuberculosis and HTLV-1 co- 
infected was 6.6% for IgG antibodies. A study 
conducted in Salvador a city with highest 
prevalence of HTLV-1 in Brazil, found that 11% of 
patients hospitalised with Tuberculosis were 
infected with HTLV-1(16). Similarly, it was 
documented that in Guinea Bissau a West African 
country infection with HTLV-1 alone is not 
sufficient enough to increase the risk of 
Tuberculosis, however HTLV-1 increase the risk of 
Tuberculosis among HIV patients (5). Many studies 
suggested an increase prevalence of HTLV-1 
infection with active TB (17,1,3), this is in contrast to 
the findings of Norrgren et al., 2008 (5). However, in 
Nigeria there is little or no information that 
showing the prevalence of HTLV-1 infection among 
Tuberculosis patients. Based on the results obtained 
from this study, PTB/HTLV-1 co-infection is higher 
among sexually active groups with 2(3.3%) 





CONCLUSION                                                  
Conclusively, the present research revealed a 6.6% 
and 1.3% prevalence of HTLV-1 IgG and IgM 
antibodies respectively among patients with PTB. 
Also, a higher prevalence of 2.3% has been found 
among married couples unlike widow group which 
has zero percent prevalence. Routine screening for 
HTLV-1 in TB patients may go a long way in 
exploring as well as better understanding of HTLV-
1 infection in Nigeria and   a such will provide 
sufficient tools for prevention and control of HTLV-
1 infection. 
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